{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:22:24Z","timestamp":1767183744293},"reference-count":22,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/mmr.2017.7215","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T07:15:52Z","timestamp":1502349352000},"page":"4603-4612","source":"Crossref","is-referenced-by-count":17,"title":["PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3\u03b2"],"prefix":"10.3892","volume":"16","author":[{"given":"Rui-Fang","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Mei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Fu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"key20180108002756_b1-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ajh.23282","article-title":"Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management","volume":"87","author":"Jabbour","year":"2012","journal-title":"Am J Hematol"},{"key":"key20180108002756_b2-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","article-title":"Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function","volume":"110","author":"Lim","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108002756_b3-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/107327480901600204","article-title":"Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia","volume":"16","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Cancer Control"},{"key":"key20180108002756_b4-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clml.2013.03.018","article-title":"Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: A clinical perspective and emerging treatment options","volume":"13","author":"Jabbour","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key20180108002756_b5-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2010-12-323022","article-title":"Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia","volume":"118","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"key20180108002756_b6-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1073\/pnas.1013214108","article-title":"The Pim protein kinases regulate energy metabolism and cell growth","volume":"108","author":"Beharrya","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108002756_b7-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neo.2014.05.004","article-title":"A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas","volume":"6","author":"Foulks","year":"2014","journal-title":"Neoplasia1"},{"key":"key20180108002756_b8-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1349-7006.2011.02117.x","article-title":"Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity","volume":"103","author":"Wang","year":"2012","journal-title":"Cancer Sci"},{"key":"key20180108002756_b9-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3892\/mco.2015.673","article-title":"PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells","volume":"4","author":"Xie","year":"2016","journal-title":"Mol Clin Onco"},{"key":"key20180108002756_b10-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1593\/neo.13172","article-title":"Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma","volume":"15","author":"Weirauch","year":"2013","journal-title":"Neoplasia"},{"key":"key20180108002756_b11-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood-2009-07-233445","article-title":"A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia\/lymphoma","volume":"115","author":"Lin","year":"2010","journal-title":"Blood"},{"key":"key20180108002756_b12-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1182\/blood-2012-02-412643","article-title":"Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma","volume":"120","author":"Yang","year":"2012","journal-title":"Blood"},{"key":"key20180108002756_b13-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2009-03-212852","article-title":"Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"key20180108002756_b14-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"e00081","DOI":"10.1042\/BSR20130067","article-title":"Multidrug resistance in chronic myeloid leukaemia: How much can we learn from MDR-CML cell lines?","volume":"33","author":"Rumjanek","year":"2013","journal-title":"Biosci Rep"},{"key":"key20180108002756_b15-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"724360","DOI":"10.1155\/2013\/724360","article-title":"Emerging therapeutic strategies for targeting chronic myeloid leukemia stem cells","volume":"2013","author":"Hamad","year":"2013","journal-title":"Stem Cells Int"},{"key":"key20180108002756_b16-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol"},{"key":"key20180108002756_b17-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"key20180108002756_b18-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: Implications for drug resistance","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"key20180108002756_b19-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice","volume":"103","author":"Hu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108002756_b20-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1582-4934.2007.00108.x","article-title":"Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitors","volume":"11","author":"Li","year":"2007","journal-title":"J Cell Mol Med"},{"key":"key20180108002756_b21-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1084\/jem.20130706","article-title":"Cross talk between Wnt\/\u03b2-catenin and Irf8 in leukemia progression and drug resistane","volume":"210","author":"Scheller","year":"2013","journal-title":"J Exp Med"},{"key":"key20180108002756_b22-mmr-16-04-4603","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.cellsig.2013.05.019","article-title":"Chibby drives \u03b2 catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells","volume":"25","author":"Mancini","year":"2013","journal-title":"Cell Signal"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T19:36:02Z","timestamp":1602704162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,10]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/mmr.2017.7215"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7215","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]}}}